AMRI NASDAQ
Albany Molecular Research, Inc.
1W: +0.1%
1M: +0.1%
3M: +7.8%
1Y: +46.7%
3Y: +12.6%
5Y: +550.9%
$21.74
Last traded 2017-08-31 — delisted
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Balance Sheet Trends
Total Assets
$1.2B
+39.8% ▲
5Y CAGR: +35.7%
Total Liabilities
$911M
+57.5% ▲
5Y CAGR: +74.3%
Shareholders Equity
$299M
+4.1% ▲
5Y CAGR: +7.7%
Cash & Investments
$52M
+5.4% ▲
5Y CAGR: +20.8%
Total Debt
$618M
+58.9% ▲
5Y CAGR: +154.1%
Net Debt
$566M
+66.6% ▲
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2012 | FY2013 | FY2014 | FY2015 | FY2016 |
|---|---|---|---|---|---|
| — Assets — | |||||
| Cash | $23M | $176M | $47M | $49M | $52M |
| Short-Term Investments | $956K | $0 | $0 | $0 | $0 |
| Cash & ST Investments | $24M | $176M | $47M | $49M | $52M |
| Net Receivables | $42M | $52M | $72M | $110M | $145M |
| Inventory | $28M | $32M | $50M | $89M | $167M |
| Other Current Assets | $18M | $19M | $22M | $31M | $29M |
| Total Current Assets | $113M | $279M | $191M | $280M | $393M |
| Property, Plant & Equip. | $136M | $128M | $165M | $210M | $365M |
| Goodwill & Intangibles | $3M | $3M | $94M | $290M | $396M |
| Long-Term Investments | $0 | $23M | $59M | $76M | $51M |
| Other Non-Current Assets | $0 | $11M | $5M | $26M | $4M |
| Total Non-Current Assets | $139M | $166M | $329M | $585M | $817M |
| Total Assets | $252M | $445M | $520M | $866M | $1.2B |
| — Liabilities — | |||||
| Accounts Payable | $18M | $24M | $32M | $61M | $111M |
| Short-Term Debt | $1M | $1M | $447K | $16M | $14M |
| Deferred Revenue | $3M | $7M | $11M | $15M | $13M |
| Other Current Liabilities | $13M | $12M | $5M | $8M | $37M |
| Total Current Liabilities | $36M | $44M | $49M | $99M | $176M |
| Long-Term Debt | $18M | $123M | $160M | $374M | $604M |
| Other Non-Current Liab. | $1M | $1M | $2M | $3M | $17M |
| Total Non-Current Liabilities | $19M | $127M | $162M | $380M | $662M |
| Total Liabilities | $57M | $200M | $278M | $578M | $911M |
| — Equity — | |||||
| Common Stock | $363K | $370K | $381K | $411K | $485K |
| Retained Earnings | $75M | $88M | $80M | $77M | $7M |
| Accumulated OCI | -$10M | -$11M | -$14M | -$18M | -$40M |
| Total Stockholders Equity | $206M | $246M | $242M | $287M | $299M |
| Total Liabilities & Equity | $252M | $445M | $520M | $866M | $1.2B |
| — Key Metrics — | |||||
| Total Debt | $8M | $124M | $160M | $389M | $618M |
| Net Debt | -$15M | -$52M | $113M | $340M | $566M |
| Total Investments | $956K | $23M | $59M | $76M | $51M |